FIELD: medicine, pharmaceutics.
SUBSTANCE: what is offered is an agent enhancing thrombocyte adhesion properties, representing cyclophilin A. It is shown that cyclophilin A not changing thrombocyte count increases collagen-induced thrombocyte aggregation without thrombin, and does not have an effect on ADP-induced and ristocetin-induced thrombocyte aggregation.
EFFECT: cyclophilin A provides an adhesive effect, and does not promotes development of thromboembolic complications.
3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| HAEMOSTASIS SYSTEM CORRECTOR MANIFESTING INHIBITORY ACTION ON ADHESIVE AGGREGATIVE FUNCTION OF THROMBOCYTES TO PREVENT PATHOLOGICAL THROMBOSIS | 2008 |
|
RU2373929C1 |
| METHOD OF DETERMINING PLATELET RESISTANCE TO ACETYLSALICYLIC ACID | 2013 |
|
RU2538219C2 |
| METHOD OF EVALUATING THE EFFECTIVENESS OF NON-AGGREGATE PREPARATIONS AFFECTING THE METABOLISM OF ARACHIDONIC ACID BY INHIBITION OF CYCLOOXYGENASE-1 BOTH INDIVIDUALLY AND JOINTLY WITH ADP P2Y RECEPTOR ANTAGONIST ON PLATELET MEMBRANES OF THE BLOOD TO THE PATIENT RECEIVING NON-AGGREGATE PREPARATIONS | 2010 |
|
RU2442167C1 |
| AMINOALKILDEOXY DERIVATIVE OF CELLULOSE, METHOD OF ITS PRODUCTION AND AGENT POSSESSING ANTIPLATELET ACTIVITY | 2018 |
|
RU2694342C1 |
| METHOD FOR DETECTING ANTIPLATELET DRUG RESISTANCE IN PATIENTS WITH PROGRESSING CEREBRAL ATHEROSCLEROSIS | 2012 |
|
RU2478965C1 |
| ANTIAGGREGANT | 2005 |
|
RU2353363C2 |
| METHOD OF DETERMINING ANTI-THROMBOTIC EFFECT OF ACETYLSALICYLIC ACID | 2007 |
|
RU2379684C2 |
| THROMBOCYTE AGGREGATION BEHAVIOR AND BLOOD COAGULABILITY TESTER | 2007 |
|
RU2343456C1 |
| METHOD OF DETERMINING THROMBOCYTE RESISTANCE TO DOUBLE ANTIPLATELET THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2019 |
|
RU2710272C1 |
| AGENT POSSESSING ANTIAGGREGANT ACTIVITY | 2019 |
|
RU2696583C1 |
